\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:on\\ physical\\ exam\\ she\\ was\\ a\\ well\\ developed\\,\\ well\\ nourished\\ woman\\ with\\ an\\ 8mm\\ erythematous\\-to\\-violaceous\\ round\\ plaque\\ on\\ her\\ inferior\\ left\\ ear\\ lobe\\.\\ remainder\\ of\\ the\\ physical\\ was\\ unremarkable\\ and\\ she\\ had\\ no\\ lymphadenopathy\\.\\ no\\ other\\ similar\\ lesions\\ were\\ noted\\ on\\ full\\ skin\\ exam\\.\\ the\\ plaque\\ was\\ biopsied\\ for\\ evaluation\\.\ \(0\)\
\-\ histopathology\\:\\ sections\\ revealed\\ a\\ nodular\\ lymphocytic\\ growth\\ pattern\\ with\\ positivity\\ for\\ bcl\\-2\\ and\\ cd20\\.\\ a\\ mixture\\ of\\ small\\ cleaved\\ cells\\ with\\ some\\ large\\ cells\\ were\\ present\\.\ \(0\)\
\-\ a\\ repeat\\ biopsy\\ for\\ fresh\\ tissue\\ was\\ performed\\ on\\ the\\ same\\ site\\ and\\ sent\\ for\\ flow\\ cytometry\\ which\\ showed\\ elevated\\ hla\\-dr\\,\\ and\\ a\\ small\\ population\\ of\\ cells\\ that\\ were\\ cd19\\ and\\ cd20\\ positive\\ and\\ which\\ co\\-expressed\\ cd10\\.\ \(0\)\
\-\ she\\ was\\ referred\\ to\\ hematology\\/oncology\\ for\\ further\\ evaluation\\.\\ they\\ performed\\ a\\ bone\\ marrow\\ biopsy\\ and\\ ordered\\ ct\\ scans\\,\\ esr\\,\\ cbc\\,\\ and\\ electrolyte\\ panels\\.\\ all\\ of\\ these\\ tests\\ were\\ negative\\ or\\ normal\\.\\ they\\ referred\\ her\\ to\\ radiation\\ oncology\\.\ \(0\)\
\-\ cutaneous\\ b\\-cell\\ follicular\\ lymphoma\\ \ \(0\)\
\-\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#15a\\)\ \(0\)\
\-\ submitted\\ by\\:\\ anna\\ s\\.\\ clayton\\,\\ maj\\,\\ usaf\\,\\ mc\\,\\ fs\ \(0\)\
\-\ presented\\ to\\ dermatology\\ with\\ a\\ 6\\ month\\ history\\ of\\ a\\ slowly\\ enlarging\\ nodule\\ on\\ her\\ inferior\\ left\\ ear\\ lobe\\.\\ she\\ had\\ no\\ previous\\ history\\ of\\ similar\\ lesions\\ and\\ no\\ previous\\ history\\ of\\ cancer\\.\\ the\\ growth\\ was\\ asymptomatic\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cd20\\:\\ 0\\.20110046440393986\ \(0\)\
\-\ she\\:\\ 0\\.1792679325288386\ \(0\)\
\-\ cells\\:\\ 0\\.17402436532288001\ \(0\)\
\-\ oncology\\:\\ 0\\.16107414742223225\ \(0\)\
\-\ plaque\\:\\ 0\\.15803671602795605\ \(0\)\
\-\ was\\:\\ 0\\.1574310847189992\ \(0\)\
\-\ were\\:\\ 0\\.15523456687759157\ \(0\)\
\-\ dermatology\\:\\ 0\\.14733384280400721\ \(0\)\
\-\ her\\:\\ 0\\.14110648069342618\ \(0\)\
\-\ and\\:\\ 0\\.1400155613605841\ \(0\)\
\-\ ear\\:\\ 0\\.13701632727496704\ \(0\)\
\-\ growth\\:\\ 0\\.12416082027293762\ \(0\)\
\-\ physical\\:\\ 0\\.12246818239613931\ \(0\)\
\-\ cleaved\\:\\ 0\\.12040144673904057\ \(0\)\
\-\ 15a\\:\\ 0\\.12040144673904057\ \(0\)\
\-\ anna\\:\\ 0\\.12040144673904057\ \(0\)\
\-\ clayton\\:\\ 0\\.12040144673904057\ \(0\)\
\-\ similar\\:\\ 0\\.11476174455931108\ \(0\)\
\-\ for\\:\\ 0\\.11409564329352485\ \(0\)\
\-\ previous\\:\\ 0\\.11377790894579609\ \(0\)\
\-\ exam\\:\\ 0\\.1136996204196026\ \(0\)\
\-\ on\\:\\ 0\\.11369091137031585\ \(0\)\
\-\ referred\\:\\ 0\\.11141859092695544\ \(0\)\
\-\ positivity\\:\\ 0\\.11125310542591875\ \(0\)\
\-\ cd19\\:\\ 0\\.1083079973356061\ \(0\)\
\-\ they\\:\\ 0\\.1075889414225699\ \(0\)\
\-\ biopsy\\:\\ 0\\.10554800772104671\ \(0\)\
\-\ cd10\\:\\ 0\\.10386714703810693\ \(0\)\
\-\ panels\\:\\ 0\\.10386714703810693\ \(0\)\
\-\ of\\:\\ 0\\.10313430833542882\ \(0\)\
\-\ inferior\\:\\ 0\\.10243894389939272\ \(0\)\
\-\ cytometry\\:\\ 0\\.10210476411279693\ \(0\)\
\-\ fresh\\:\\ 0\\.09915965602248426\ \(0\)\
\-\ no\\:\\ 0\\.09793083317878637\ \(0\)\
\-\ usaf\\:\\ 0\\.0979017268554629\ \(0\)\
\-\ electrolyte\\:\\ 0\\.09569690250197536\ \(0\)\
\-\ fs\\:\\ 0\\.0929564227996751\ \(0\)\
\-\ 8mm\\:\\ 0\\.0921562828757016\ \(0\)\
\-\ maj\\:\\ 0\\.0921562828757016\ \(0\)\
\-\ evaluation\\:\\ 0\\.0918293447417177\ \(0\)\
\-\ mixture\\:\\ 0\\.08936736911301067\ \(0\)\
\-\ performed\\:\\ 0\\.08908091632796764\ \(0\)\
\-\ biopsied\\:\\ 0\\.08875338554234108\ \(0\)\
\-\ sections\\:\\ 0\\.08760498618770068\ \(0\)\
\-\ lobe\\:\\ 0\\.0870166876983942\ \(0\)\
\-\ lesions\\:\\ 0\\.08647717772665593\ \(0\)\
\-\ history\\:\\ 0\\.08629279696552962\ \(0\)\
\-\ follicular\\:\\ 0\\.08605045427687369\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.08465987809738802\ \(0\)\
\-\ submitted\\:\\ 0\\.07960504422921924\ \(0\)\
\-\ mc\\:\\ 0\\.07901835801397802\ \(0\)\
\-\ cutaneous\\:\\ 0\\.07818450602405143\ \(0\)\
\-\ small\\:\\ 0\\.07767187814965254\ \(0\)\
\-\ nourished\\:\\ 0\\.07714881671940632\ \(0\)\
\-\ histopathology\\:\\ 0\\.07595897850295431\ \(0\)\
\-\ seminar\\:\\ 0\\.0757333616133365\ \(0\)\
\-\ to\\:\\ 0\\.07528712361847993\ \(0\)\
\-\ uniformed\\:\\ 0\\.0750787679594126\ \(0\)\
\-\ had\\:\\ 0\\.07502221564309687\ \(0\)\
\-\ 1997\\:\\ 0\\.07445511178541904\ \(0\)\
\-\ slowly\\:\\ 0\\.07425360761724482\ \(0\)\
\-\ services\\:\\ 0\\.07385960024945794\ \(0\)\
\-\ well\\:\\ 0\\.07290936564540257\ \(0\)\
\-\ tests\\:\\ 0\\.0720487832637573\ \(0\)\
\-\ population\\:\\ 0\\.07122875144959064\ \(0\)\
\-\ sent\\:\\ 0\\.07045670291609742\ \(0\)\
\-\ enlarging\\:\\ 0\\.07030756837288833\ \(0\)\
\-\ esr\\:\\ 0\\.06890217100527041\ \(0\)\
\-\ which\\:\\ 0\\.06846814633006527\ \(0\)\
\-\ remainder\\:\\ 0\\.0662536656587634\ \(0\)\
\-\ ordered\\:\\ 0\\.06614503733653987\ \(0\)\
\-\ repeat\\:\\ 0\\.06603729578601987\ \(0\)\
\-\ scans\\:\\ 0\\.06551139886030961\ \(0\)\
\-\ cbc\\:\\ 0\\.06281610769152143\ \(0\)\
\-\ marrow\\:\\ 0\\.06256629076999694\ \(0\)\
\-\ round\\:\\ 0\\.061688741435587086\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.06086592017479803\ \(0\)\
\-\ site\\:\\ 0\\.060721675387734354\ \(0\)\
\-\ the\\:\\ 0\\.06009050880695375\ \(0\)\
\-\ nodular\\:\\ 0\\.059955333860322785\ \(0\)\
\-\ same\\:\\ 0\\.05955535577691957\ \(0\)\
\-\ nodule\\:\\ 0\\.05942467880202065\ \(0\)\
\-\ with\\:\\ 0\\.058969103462904966\ \(0\)\
\-\ full\\:\\ 0\\.05885213409316267\ \(0\)\
\-\ pattern\\:\\ 0\\.05620928959454203\ \(0\)\
\-\ skin\\:\\ 0\\.056007013349580054\ \(0\)\
\-\ developed\\:\\ 0\\.05585731495860224\ \(0\)\
\-\ left\\:\\ 0\\.051364563339221875\ \(0\)\
\-\ elevated\\:\\ 0\\.051324637977397204\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.05125443426588909\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05047284136656245\ \(0\)\
\-\ flow\\:\\ 0\\.05014694168143796\ \(0\)\
\-\ showed\\:\\ 0\\.05014694168143796\ \(0\)\
\-\ cancer\\:\\ 0\\.05014694168143796\ \(0\)\
\-\ radiation\\:\\ 0\\.04989189477595823\ \(0\)\
\-\ positive\\:\\ 0\\.049610737635606195\ \(0\)\
\-\ revealed\\:\\ 0\\.04936575117442358\ \(0\)\
\-\ further\\:\\ 0\\.049036151905071705\ \(0\)\
\-\ some\\:\\ 0\\.0473702968172785\ \(0\)\
\-\ negative\\:\\ 0\\.04661010976265032\ \(0\)\
\-\ month\\:\\ 0\\.04579838733100518\ \(0\)\
\-\ lymphoma\\:\\ 0\\.044838496204038465\ \(0\)\
\-\ all\\:\\ 0\\.04481698313220965\ \(0\)\
\-\ presented\\:\\ 0\\.043903531055776615\ \(0\)\
\-\ these\\:\\ 0\\.0425149608443235\ \(0\)\
\-\ bone\\:\\ 0\\.04107932396335239\ \(0\)\
\-\ noted\\:\\ 0\\.03991743634321018\ \(0\)\
\-\ tissue\\:\\ 0\\.03949423841554526\ \(0\)\
\-\ woman\\:\\ 0\\.0392100882231139\ \(0\)\
\-\ other\\:\\ 0\\.03909811922372314\ \(0\)\
\-\ present\\:\\ 0\\.03863257192878959\ \(0\)\
\-\ case\\:\\ 0\\.037823729415974325\ \(0\)\
\-\ large\\:\\ 0\\.03772288257083003\ \(0\)\
\-\ that\\:\\ 0\\.03267204497695324\ \(0\)\
\-\ by\\:\\ 0\\.03197153035230639\ \(0\)\
\-\ normal\\:\\ 0\\.030739469278828042\ \(0\)\
\-\ an\\:\\ 0\\.028789769560010763\ \(0\)\
\-\ ct\\:\\ 0\\.02866274002651816\ \(0\)\
\-\ or\\:\\ 0\\.026191255505663223\ \(0\)\
